PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer - Join Clinical Trial NCTNCT04360941
How to Join This Clinical Trial - NCTNCT04360941
Learn how to participate in this PHASE1 trial studying an investigational therapy for Breast Neoplasms, Triple Negative Breast Neoplasms. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Breast Neoplasms, Triple Negative Breast Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Breast Neoplasms, Triple Negative Breast Neoplasms
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1 - Early safety study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT04360941 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 9 locations. Find a study site near you:
Clinical Research Site
Manchester, Greater Manchester M20 4BX - United Kingdom
Status: RECRUITING
Clinical Research Site
Cambridge, CB2 0QQ - United Kingdom
Status: RECRUITING
Clinical Research Site
Glasgow, G12 0YN - United Kingdom
Status: RECRUITING
Clinical Research Site
Leicester, LE1 5WW - United Kingdom
Status: RECRUITING
Clinical Research Site
London, EC1M 6BQ - United Kingdom
Status: RECRUITING
Clinical Research Site
London, SW3 6JJ - United Kingdom
Status: RECRUITING
Clinical Research Site
London, W1T 7HA - United Kingdom
Status: RECRUITING
Clinical Research Site
Nottingham, NG5 1PB - United Kingdom
Status: RECRUITING
Clinical Research Site
Sheffield, S10 2SJ - United Kingdom
Status: RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE1 clinical trial for Breast Neoplasms, Triple Negative Breast Neoplasms:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships